IRADIMED CORP — Director's Dealing 2020

Dec 9, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2020-12-04

Reporting Person: Scott Christopher K. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-04	Common Stock	M	2952	—	Acquired	23984	Direct
2020-12-04	Common Stock	F	719	$24.9	Disposed	23265	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-04	Restricted Stock Units	$	M	2952	Disposed		Common Stock (2952)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: On December 4, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.